Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 28 March 1986:
Vol. 231. no. 4745, pp. 1549 - 1553
DOI: 10.1126/science.3006244

Articles

Science, Vol 231, Issue 4745, 1549-1553
Copyright © 1986 by American Association for the Advancement of Science


articles

Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions

J Sodroski, WC Goh, C Rosen, A Tartar, D Portetelle, A Burny, and W Haseltine

The genome of the human T-lymphotropic virus type III (HTLV-III/LAV) has the potential to encode at least three polypeptides in addition to those encoded by the gag, pol, and env genes. In this study, the product of the sor (short open reading frame) region, which overlaps the 3' end of the pol gene, was found to be a protein with a molecular weight of 23,000. An assay was developed for testing the ability of cloned HTLV-III proviruses to produce viruses cytopathic for T4+ lymphocytes. In the cell line used, C8166, neither the HTLV-III sor gene product nor the complete 3'-orf gene product were necessary for the replication or cytopathic effects of the HTLV-III.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state.
T. H. Reingewertz, H. Benyamini, M. Lebendiker, D. E. Shalev, and A. Friedler (2009)
Protein Eng. Des. Sel. 22, 281-287
   Abstract »    Full Text »    PDF »
Inhibition of Formula-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication.
F. Guo, S. Cen, M. Niu, J. Saadatmand, and L. Kleiman (2006)
J. Virol. 80, 11710-11722
   Abstract »    Full Text »    PDF »
Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging.
K. Luo, B. Liu, Z. Xiao, Y. Yu, X. Yu, R. Gorelick, and X.-F. Yu (2004)
J. Virol. 78, 11841-11852
   Abstract »    Full Text »    PDF »
The Interaction between HIV-1 Gag and APOBEC3G.
S. Cen, F. Guo, M. Niu, J. Saadatmand, J. Deflassieux, and L. Kleiman (2004)
J. Biol. Chem. 279, 33177-33184
   Abstract »    Full Text »    PDF »
Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication.
Y.-H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B. M. Peterlin (2004)
J. Virol. 78, 6073-6076
   Abstract »    Full Text »    PDF »
Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G.
B. Liu, X. Yu, K. Luo, Y. Yu, and X.-F. Yu (2004)
J. Virol. 78, 2072-2081
   Abstract »    Full Text »    PDF »
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex.
X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.-F. Yu (2003)
Science 302, 1056-1060
   Abstract »    Full Text »    PDF »
Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Two-Amino-Acid Insertion in HIV-1 Vif from a Nonprogressing Mother and Child.
L. Alexander, M. J. Aquino-DeJesus, M. Chan, and W. A. Andiman (2002)
J. Virol. 76, 10533-10539
   Abstract »    Full Text »    PDF »
Functional Neutralization of HIV-1 Vif Protein by Intracellular Immunization Inhibits Reverse Transcription and Viral Replication.
J. Goncalves, F. Silva, A. Freitas-Vieira, M. Santa-Marta, R. Malho, X. Yang, D. Gabuzda, and C. Barbas III (2002)
J. Biol. Chem. 277, 32036-32045
   Abstract »    Full Text »    PDF »
Vif Is Largely Absent from Human Immunodeficiency Virus Type 1 Mature Virions and Associates Mainly with Viral Particles Containing Unprocessed Gag.
P. Sova, D. J. Volsky, L. Wang, and W. Chao (2001)
J. Virol. 75, 5504-5517
   Abstract »    Full Text »    PDF »
Role of Vif in Stability of the Human Immunodeficiency Virus Type 1 Core.
A. Ohagen and D. Gabuzda (2000)
J. Virol. 74, 11055-11066
   Abstract »    Full Text »    PDF »
Association of Human Immunodeficiency Virus Type 1 Vif with RNA and Its Role in Reverse Transcription.
M. Dettenhofer, S. Cen, B. A. Carlson, L. Kleiman, and X.-F. Yu (2000)
J. Virol. 74, 8938-8945
   Abstract »    Full Text »    PDF »
Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis.
G. Herbein and W. A. O'brien (2000)
Experimental Biology and Medicine 223, 241-257
   Abstract »    Full Text »
Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of Vif for optimal infectivity: functional difference between Vif and Nef.
H. Akari, T. Uchiyama, T. Fukumori, S. Iida, A. H. Koyama, and A. Adachi (1999)
J. Gen. Virol. 80, 2945-2949
   Abstract »    Full Text »
Highly Purified Human Immunodeficiency Virus Type 1 Reveals a Virtual Absence of Vif in Virions.
M. Dettenhofer and X.-F. Yu (1999)
J. Virol. 73, 1460-1467
   Abstract »    Full Text »    PDF »
Conservation of an Intact vif Gene of Human Immunodeficiency Virus Type 1 during Maternal-Fetal Transmission.
V. R. K. Yedavalli, C. Chappey, E. Matala, and N. Ahmad (1998)
J. Virol. 72, 1092-1102
   Abstract »    Full Text »    PDF »
A novel gene of HIV-1, vpu, and its 16-kilodalton product.
K Strebel, T Klimkait, and M. Martin (1988)
Science 241, 1221-1223
   Abstract »    PDF »
Human immunodeficiency virus may encode a novel protein on the genomic DNA plus strand.
R. Miller (1988)
Science 239, 1420-1422
   Abstract »    PDF »
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.
T. Folks, J Justement, A Kinter, C. Dinarello, and A. Fauci (1987)
Science 238, 800-802
   Abstract »    PDF »
The sor gene of HIV-1 is required for efficient virus transmission in vitro.
A. Fisher, B Ensoli, L Ivanoff, M Chamberlain, S Petteway, L Ratner, R. Gallo, and F Wong-Staal (1987)
Science 237, 888-893
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)